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We examined the inhibitory effects of three flavonolignans and their dehydro- derivatives,
taxifolin and quercetin on the activity of the Na+/K+-ATPase (NKA). The flavonolignans
silychristin, dehydrosilychristin and dehydrosilydianin inhibited NKA with IC of 110±50 40
µM, 38 ± 8 µM, and 36 ± 14 µM, respectively. Using the methods of molecular
modeling, we identified several possible binding sites for these species on NKA and
proposed the possible mechanisms of inhibition. The binding to the extracellular- or
cytoplasmic C-terminal sites can block the transport of cations through the plasma
membrane, while the binding on the interface of cytoplasmic domains can inhibit the
enzyme allosterically. Fluorescence spectroscopy experiments confirmed the interaction
of these three species with the large cytoplasmic segment connecting transmembrane
helices 4 and 5 (C45). The flavonolignans are distinct from the cardiac glycosides that are
currently used in NKA treatment. Because their binding sites are different, the mechanism
of inhibition is different as well as the range of active concentrations, one can expect that
these new NKA inhibitors would exhibit also a different biomedical actions than cardiac
glycosides.
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INTRODUCTION
Sodium pump (Na+/K+-ATPase, E.C. 3.6.3.9, NKA) is an enzyme of crucial importance for all
animal cells. It is the major determinant of cytoplasmic Na+ and K+ concentrations and the
resting plasma membrane potential. The steep Na+ gradient on plasma membrane is essential
for variety of secondary active transporters, e.g., Na+/Ca2+- and Na+/H+- exchanger or Na+-
dependent glucose transporter, and hence, NKA indirectly regulates also concentrations of other
physiologically important solutes.
It is not surprising that an uncontrolled inhibition of NKA can result in severe diseases, e.g.,
renal failure, hypertension or diabetic neuropathies (Kaplan, 2002) or even death, and that the
most specific NKA inhibitor cardiac glycoside ouabain was originally used as an arrow poison
(Newman et al., 2008). Despite these risks, extracts containing cardiac glycosides were used to
control heart tonics already in ancient medicine, and the extracts were prepared either from plants
in Arabic medicine (Brewer, 2004) or secretions of frog Bufo bufo in Chinese medicine (Watabe
et al., 1996). Compounds like digitalis or digoxin are still prescribed for control of congestive heart
failure (Gheorghiade et al., 2004). However, the use of cardiac glycosides is limited by their very
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narrow useful concentration range (Newman et al., 2008), which
stimulates further search for other NKA inhibiting compounds.
Silymarin is an extract from the seeds of milk thistle (Silybum
marianum). It contains numerous polyphenolic compounds and
it was shown to possess antioxidant (Vacek et al., 2013; Pyszková
et al., 2015), hepatoprotective (Loguercio and Festi, 2011) or
anticancer effects (Agarwal et al., 2006). In this study, we have
tested effects on NKA activity for a flavonoid taxifolin (TAX)
and three flavonolignans, namely silybin (SB), silychristin (SCH),
and silydianin (SD), which are major silymarin compounds
(Biedermann et al., 2014); their structures are shown in Figure 1.
The corresponding 2,3-dehydro derivatives (DHSB, DHSCH,
and DHSD, the 2,3-dehydrotaxifolin is termed quercetin, QUE)
were also tested.
The NKA catalytic cycle is usually described by the Albers-
Post cycle (Jorgensen et al., 2003). It postulates that during the
catalytic cycle, the enzyme adopts two major conformations,
denoted as E1 and E2. In E1, the enzyme has high affinity to
sodium and ATP and the binding sites are open to the cytoplasm,
while in E2, the enzyme has high affinity to potassium, low affinity
to ATP and the cation-binding sites are open to the extracellular
space. High-resolution structures of NKA were obtained in
several conformational states thanks to recent progresses in X-ray
crystallography of membrane proteins (Morth et al., 2007; Ogawa
FIGURE 1 | Structures of silybin (SB), silychristin (SCH), silydianin (SD) and their dehydro-derivatives (DHSB, DHSCH, DHSD), taxifolin (TAX), and
quercetin (QUE). The 2,3-double bond in dehydroderivatives is highlighted in red.
et al., 2009; Nyblom et al., 2013). They revealed the binding
sites for transported cations within the transmembrane domain,
or binding site for some ligands, including ouabain. Notably,
in the crystals assigned to the enzyme in E1 conformation, the
cytoplasmic domains are assembled together (further referred to
as a closed conformation), while in the E2 conformation, the
cytoplasmic headpiece is widely opened (opened conformation).
These different structures provided a solid basis to figure out
molecular processes responsible for the mechanisms of enzyme
inhibition. Moreover, based on these high-resolution structures,
molecular modeling allows further identification of the binding
sites of flavonolignans that inhibit NKA, and strongly support
rationalization of mechanisms of inhibition.
MATERIALS AND METHODS
Chemicals
Unless stated otherwise, all used chemicals were from Sigma-
Aldrich Chemie (Steinheim, Germany).
Species Tested for the Effect on NKA
Activity
Silymarin was purchased from Liaoning Senrong Pharmaceutical
Co., Ltd. (China), SB, SCH, and SD were isolated from the
Frontiers in Physiology | www.frontiersin.org 2 March 2016 | Volume 7 | Article 115
Kubala et al. Flavonolignans—Novel Sodium Pump Inhibitors
silymarin, and the dehydro- derivatives DHSB, DHSCH and
DHSD were prepared as described previously (Džubák et al.,
2006; Krˇenek et al., 2014; Pyszková et al., 2015). Silybin and
silychristin were used as the natural diastereomeric mixture
(ca. 1/1 and 95/5 respectively), silydianin is a single isomer.
Dehydroderivatives were prepared from parent mixtures and
are therefore enantiomeric mixtures (besides DHSD) (Pyszková
et al., 2015). Taxifolin was purchased from Amagro (CZ).
Quercetin was prepared by acidic hydrolysis of rutin with
HCl/EtOH as described previously (Wang et al., 2011). Purity of
all used compounds was over 95% (HPLC, PDA).
Isolation of Na+/K+-ATPase
The NKAwas prepared from porcine kidney outer medulla using
the method of Jorgensen and Klodos with some modifications
(Jørgensen, 1988; Klodos et al., 2002; Kubala et al., 2014). An
isolated enzyme was pipetted into small aliquots and stored
at −20◦C in ISE buffer (25 mM imidazole, 250 mM sucrose,
1 mM EDTA, pH 7.4) containing SDS detergent. The molar
concentration of isolated NKA was estimated using the Bradford
method with consideration of MW(α + β) = 165,000 Da. The
protein purity >90% was estimated from SDS-PAGE (Figure 2).
Measurement of ATPase Activity
The measurements of NKA activity were performed using the
Baginsky assay (Kubala et al., 2014). The assay was performed in
microwell plates in 4 replicates for each point and automated in
the pipetting station Freedom EVO (Tecan, Switzerland).
The reaction buffer was composed of 325 mM NaCl, 50 mM
KCl, 7.5 mM MgCl2, and 75 mM imidazole, pH 7.2. In the
experiments where the K+-dependence was estimated, the KCl
concentration is ranging from 0 to 100 mM. The NKA (0.1
FIGURE 2 | Purity of isolated NKA (left) and C45 (right) as revealed by
SDS-PAGE.
mg/mL) isolated from porcine kidney was mixed with reaction
buffer without ATP. All inhibitors were solubilized in methanol
immediately before the measurement and then premixed with
the reaction buffer to the required concentration. Subsequently,
10 µL of inhibitor solution was added into 20 µL of enzyme
solution and incubated for 2 min. In the control sample, only
10 µL of reaction buffer without inhibitor was added including
corresponding amount of methanol. The reaction was started by
the addition of ATP solution (20µL, 7.5mM in the stock, the final
concentration in the reaction was 3mM). The reaction proceeded
for 6 min at room temperature and then was stopped by addition
of 75 µL of staining solution, which was composed of 160 mM
ascorbic acid, 3.7% (v/v) acetic acid, 3% (w/v) SDS, and 0.5%
ammonium molybdate. The staining reaction was stopped after
another 8 min by adding 125 µL of solution composed of 0.9%
(w/v) bismuth citrate, 0.9% (w/v) sodium citrate and 3.7% HCl.
The Baginsky method detects a product of ATP hydrolysis,
inorganic phosphate, which interacts with ammonium
molybdate. The reaction results in a color change, which
can be monitored as a change of absorbance at 710 nm, and was
measured using microplate reader Synergy Mx (BioTek, USA).
The calibration line was determined using KH2PO4 solutions, in
0–37.5 nM concentration range.
The specific NKA activity is standardly estimated using the
treatment by ouabain, which serves as a specific inhibitor of NKA.
The ATPase activity decreases to less than 10% in the presence
of 10 mM ouabain. This residual activity in the presence of
ouabain was subtracted from the total estimated ATPase activity
in ouabain-untreated samples, and all data are presented as the
ouabain-sensitive ATPase activity. The IC50 values were obtained
from fitting the data to the logistic function.
Expression and Purification of the Isolated
Large Cytoplasmic Segment C45
The large cytoplasmic segment connecting the transmembrane
helices 4 and 5 (C45 loop, residues L354-I777 of the mouse brain
sequence) with a (His)6-tag at the N-terminus was expressed in
E. coli BL21 (Promega, USA) and purified using a Co2+-based
affinity resin (Clontech, USA) as described previously (Grycova
et al., 2009). Immediately after elution, the protein was dialyzed
into 20 mM Tris, 140 mM NaCl, pH 7.4 buffer and stored
at−20◦C.
Protein were analyzed by Coomassie blue stained SDS PAGE
and concentration was determined using the Bradford assay
(Bradford, 1976) using BSA as a standard.
Absorption and Fluorescence
Spectroscopy
Spectroscopic experiments were performed in 20 mM Tris, 140
mM NaCl, pH 7.4 buffer. SCH, DHSCH and DHSD as well as
protein C45 were diluted to 5 µM concentration.
Absorption spectra were measured on spectrometer Specord
250 Plus (Analytic Jena, Germany) in the range 300–600 nm, with
the bandpass 2 nm, a step 1 nm and a scan-speed 2 nm/s. The
reference spectrum was acquired using the cuvette with a pure
buffer.
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Fluorescence emission spectra were measured using
Fluorolog-3 (Horiba Scientific, USA). The spectra were scanned
with a step of 1 nm, both excitation- and emission bandpass 5
nm and integration time 1 s. For SCH, the excitation was 325
nm and emission was recorded in the 340–600 nm interval, for
DHSCH and DHSD, the excitation wavelength was 380 nm and
spectra were scanned in the 400–600 nm interval. Signal from
pure buffer was subtracted as a background.
Computation of Structures for Molecular
Docking
Geometry optimizations of all structures (Figure 1) was
performed using the density functional theory (DFT) formalism
with the software package Gaussian09 (Frisch et al., 2009). The
hybrid functional B3P86 has been used because it has repeatedly
succeeded in describing most of polyphenol properties (Trouillas
et al., 2006, 2008). Gibbs energies (G) were computed at
B3P86/6-31+G(d,p) level at 298 K, 1 atm. After a vibrational
frequency analysis, ground-state geometries were confirmed by
the absence of any imaginary frequency. Quantum calculations
were performed in the gas phase.
The SB (stereoisomer A) and DHSB (stereoisomer A) initial
structures were taken from Trouillas et al. (2008) and further
re-optimized. Structure of the most stable isomers of SCH
(stereoisomer A), DHSCH (stereoisomer A), SD and DHSD were
already presented in Pyszková et al. (2015).
Molecular Docking
The compounds SCH, DHSCH, and DHSD were docked to
the opened and closed structures of NKA (PDB, ID, 3KDP,
and 4HQJ) using Autodock Tools (Morris et al., 2009) and
Autodock Vina (Trott and Olson, 2010) with the grid covering
the whole protein. The values of parameters exhaustiveness
was set to 100 and num_modes to 9999 in order to reveal
all possible docking modes. In the default setting, the bonds
creating different conformers were freely rotable, to find optimal
geometry of molecules interacting with the pump.
RESULTS
Conformational Analysis
Conformational analysis of both flavonoids TAX and its dehydro-
analog QUE revealed two stable rotamers. In case of QUE,
as reported previously (Trouillas et al., 2006), the planarity is
observed, allowing pi electron delocalization along the A, C and
B rings, while for TAX, the planarity is lost due to the loss of the
2,3-double bond.
A conformation analysis of SB, DHSB, SCH, DHSCH, SD,
and DHSD revealed 4 most stable representative conformers
for all molecules within less than 1.6 kcal/mol difference in
Gibbs energy (Figure 3). These conformers can be obtained
by modification of the torsion angles Phi = C3–C2–C14–
C15 and Psi = C11–C10–C22–C17 (Psi = C10–C11–C17–
C22 for SB and DHSB) (Table 1), and the loss of the
flavonoid moiety planarity is observed also for these molecules,
when the 2,3-bond is hydrogenated (DHSB, DHSCH, and
DHSD).
Effects on NKA Activity
Ouabain-sensitive ATPase activity was measured for increasing
concentrations of all species (Figure 4). In the case of SB,
DHSB, SD, and DHSD, the examined concentration range was
FIGURE 3 | Structures of stable conformers of DHSCH.
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TABLE 1 | Structural parameters of the stable conformers.
Species Conformer Phi (◦) Psi (◦) Relative Gibbs
energy (kcal/mol)
SB 1 77 −98 0
2 83 81 0.4
3 −96 −97 0.2
4 −98 81 0.2
DHSB 1 3 −98 0
2 −1 80 0.3
3 −178 −98 0.1
4 −176 83 0.5
SCH 1 81 −71 0
2 82 98 0.9
3 −105 52 0.1
4 −97 −141 0.7
DHSCH 1 174 −52 0
2 175 87 0.2
3 9 97 0.1
4 7 −55 1.6
SD 1 −3 −37 0
2 −5 147 0.2
3 −125 −42 0.5
4 −123 142 0.4
DHSD 1 1 −45 0
2 1 142 0.3
3 166 −40 0.2
4 166 145 0.8
TAX 1 −83 0
2 80 0.1
QUE 1 180 0
2 0 0.4
limited due to lower solubility of these species. Substantial
inhibition was observed only for SCH, DHSCH and DHSD
with IC50 110 ± 40 µM, 38 ± 8 µM, and 36 ± 14
µM, respectively. In all these cases, we observed a Hill
coefficient < 1, indicating the presence of multiple binding
sites and negative cooperativity. The data are summarized in
Table 2, and SCH, DHSCH, and DHSD were subject to further
analyses.
We have tested influence of these three species on the ouabain
inhibition and K+-dependence of NKA activation. None of the
species substantially influenced the IC50 for ouabain or the
K+/ouabain antagonism (Figure 5). The NKA activity is K+-
dependent and it increased with increasing concentration of
potassiumwith K0.5(K+)= 4.2± 0.6 mM. In contrast to ouabain,
which raised the K0.5(K+) to 14.8 ± 0.1 mM, none of the
flavonolignans significantly altered the K+-dependence of NKA
activity (Figure 6).
FIGURE 4 | Inhibition of NKA by (A) SB (squares), SCH (circles), SD (up
triangles), TAX (down triangles) and (B) by the corresponding dehydro-
derivatives DHSB, DHSCH, DHSD and QUE. The reference value (100%)
represents ouabain-specific activity of untreated NKA.
Molecular Docking
Molecular docking enables prediction of the binding sites for
small ligands on large biomolecules. Binding to NKA was
examined for both major conformations of the enzyme. All
SCH, DHSCH, and DHSD bound with a similar affinities
(−11 to −9 kcal/mol) to all sites in both opened and
closed conformations. We identified five major binding sites,
three of them were common to both the opened and closed
conformations (Figure 7), one binding pose was exclusively
observed only for the opened conformation, and another one in
turn only for closed conformation. All conformers bound to at
least one binding site, nevertheless, their relative preferences for
individual binding sites differed (Table 3).
In the closed conformation, by far the most favored site was
near the phosphorylation site. All the conformers can occupy
this site, except for conformer 4 of DHSCH. All compounds
bound also to another pose between the A and N domains on
the other side near R248 (Figure 8). However, this site only
exists in the closed conformation. It is much more selective and
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TABLE 2 | Values of IC50 for inhibition of the NKA activity, n, Hill
coefficient, K0.5(ouabain) indicates the value obtained in the presence of
5 mM KCl (in parentheses in 40 mM KCl) and 40 µM concentration of
flavonolignan, K0.5(K
+) denotes the values for K+-dependent activation
of NKA obtained in the presence of 40 µM flavonolignan, n.d., not
determined.
Species IC50 (µM) n K0.5(ouabain) (µM) K0.5(K
+) (mM)
None 2.6 ± 1.3 (23 ± 3) 4.2 ± 0.6
SB >1000 n.d. n.d. n.d.
DHSB 900 ± 800 0.5 ± 0.1 n.d. n.d.
SCH 110 ± 40 0.6 ± 0.1 4.0 ± 1.7 (18 ± 2) 8 ± 5
DHSCH 38 ± 8 0.8 ± 0.1 1.5 ± 0.5 (24 ± 6) 4 ± 1
SD >1000 n.d. n.d. n.d.
DHSD 36 ± 14 0.6 ± 0.1 3.3 ± 1.4 (19 ± 7) 3 ± 2
TAX >1000 n.d. n.d. n.d.
QUE >1000 n.d. n.d. n.d.
FIGURE 5 | The K+/ouabain antagonism in the absence (squares) or in
the presence of 40 µM SCH (circles), DHSCH (up triangles) or DHSD
(down triangles).
can be occupied only by conformer 3 of SCH, conformers 2
and 4 of DHSCH and conformer 1 of DHSD. Another possible
binding location in the closed structure is on the extracellular side
between E312 on TM4 and R886 (extracellular loop connecting
TM7 and TM8), and it is the most favored site for conformer
4 of DHSCH. This site can serve as the entry for potassium
ions during transport. Conformer 1 of SCH and conformers
1 and 4 of DHSCH are the only molecules that bind at the
intracellular C-terminal site. Also this site was proposed to play
a role in transport of cations through the plasma membrane
(Toustrup-Jensen et al., 2009).
Also in the opened conformation, the binding to the groove
between P and N cytoplasmic domains near the phosphorylation
site was observed for all conformers, except for conformer 3 of
DHSCH. It was the most preferred site for all SCH conformers
and for conformers 1 of DHSCH and DHSD. The binding site
specific only for the opened conformation is located under A
FIGURE 6 | The K+-dependence of NKA activity in the absence of any
ligand (squares) or in the presence of ouabain (circles), SCH (up
triangles), DHSCH (down triangles) or DHSD (diamonds).
domain, near the residues N353 and D740, where a regulatory
potassium ion is bound (Schack et al., 2008). It is the most
preferred site for conformers 2 and 4 of DHSCH and for
conformer 2 of DHSD, but numerous other conformers can bind
in this site as well. The site at the extracellular potassium entrance
is the most preferred for the conformer 4 of DHSD. There is also
a binding pose at the C-terminal of the protein, but it can be
occupied only by DHSCH or DHSD, and for conformer 3 of both
species it is the most preferred site.
Interaction with the Isolated Large
Cytoplasmic Segment C45
Based on the prediction from molecular docking, we examined
whether SCH, DHSCH, and DHSD could interact with the
isolated large cytoplasmic segment C45 using absorption and
fluorescence spectroscopy. Absorption spectra of SCH, DHSCH,
and DHSD exhibited maxima at ca. 325, 385, and 375 nm,
respectively, and the presence of C45 did not substantially alter
the spectra (not shown), thus, providing no further clue about
the interaction.
On the other hand, the interaction with C45 was clearly
manifested in the fluorescence spectra for all three species.
We observed no detectable fluorescence above background for
the free SCH. The interaction with C45 protein turned out
to be fluorogenic, and in the presence of C45, a bright SCH
fluorescence appeared (quantum yield increased more than 1000
times compared to the free SCH) with a maximum at 394 nm
(Figure 9). For the free DHSCH, we observed only very weak
fluorescence with a maximum at 537 nm and an apparent
shoulder at ca. 475 nm. In the presence of C45, the fluorescence
intensity increased ca. 3-times, and two peaks at 466 and 527 nm
could be resolved. Similarly for the free DHSD, there is only a
weak fluorescence with a maximum at 472 nm. In the presence of
C45, the three-fold intensity increase is accompanied by a shift of
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FIGURE 7 | Binding sites of SCH (yellow), DHSCH (cyan) and DHSD (magenta) on the opened and closed structure. Beta subunit is in light green, the FXYD
protein light orange, A, domain blue; N, domain red; P, domain green.
the maximum to 459 nm, and there is also an apparent shoulder
at 510 nm.
DISCUSSION
Recent pharmacology greatly benefits from the species isolated
from the plants used in traditional medicine. In addition, these
species also serve as precursors or inspiration for synthesis of new
active derivatives, which can turn out to be even more effective in
biochemical interactions. This study was focused on interactions
of a series of phenolic compounds from silymarin (being or not
hydrogenated on 2,3-bond of the flavonoid moiety) with one of
the most important enzymes in the animal metabolism, the NKA.
Bioavailability of most polyphenolic compounds naturally
found in silymarin is limited by their lower solubility in water,
only SCH and SD exhibit substantially higher solubility in
aqueous environment. In our experiments, we observed that only
SCH inhibited the NKA with IC50 of 110 ± 40 µM, and similar
concentrations can hardly be reached within the living organism.
On the other hand, two of the 2,3-dehydroderivatives, DHSCH
and DHSD, inhibited NKA substantially more efficiently with
IC50 of 38 ± 8 µM and 36 ± 14 µM, respectively. Interestingly,
none of the flavonolignans exhibited influence on the known
K+/ouabain antagonism (Müller-Ehmsen et al., 2001). Moreover,
in contrast to ouabain, they did not alter the K+-dependence of
NKA activity, suggesting that the flavonolignans have different
mode of inhibition than ouabain.
Interaction of small molecules with large biomolecules is one
of the key issues in structural biology, and recently, it has gained
benefits from the development in computational techniques. The
classical key-and-lock concept assumes that small molecules can
specifically interact with enzymes when their geometries fit each
other. The induced-fit concept that was proposed later, has not
that strict requirements on the geometries of the interaction
partners, and it assumes that after the first contact, the enzyme
can rearrange its conformation to fit the shape of the small ligand
(Koshland, 1995).
Our calculations revealed that all flavonolignans (including
the dehydro- derivatives) can adopt several stable conformations.
Their stabilizing energies calculated in the gas phase appeared
very similar, suggesting that they are all present in solution
in roughly equimolar mixtures. Although differences between
flavonolignans conformers may play no important role in, e.g.,
their redox properties, the precise geometry is crucial in the
interaction with enzymes, and some conformers can be tightly
bound to the enzyme, while the others can be inactive.
However, the situation is probably more complex in our case.
The fitting of the inhibition curves revealed the Hill coefficient
different from 1 for all SCH, DHSCH, and DHSD, indicating the
presence of multiple binding sites. Indeed, molecular docking
revealed one extracellular binding site and four other sites in
the cytoplasmic segment of the protein, indicating multiple
possibilities of how the flavonolignans could inhibit the enzyme.
The main enzyme function is translocation of cations through
the plasma membrane. The cations are transiently bound to their
binding sites formed by residues TM4, TM5, TM6, and TM8
in the transmembrane domain (Morth et al., 2007), while the
extracellular- and cytoplasmic pathways to these binding sites
alternatively open and close. Binding of flavonolignans to the
extracellular binding site or to the C-terminal binding site can
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efficiently block these pathways, and thus, can stop the cation
transport. The opening and closing of the extracellular- and
cytoplasmic gates is accompanied by the change in the position
of cytoplasmic domains, as a consequence of ATP-binding and
hydrolysis (Kubala, 2006). Localization of the flavonolignan on
the interfaces between N- and P- or N- and A-domains can
TABLE 3 | The fractions of conformers bound to the selected binding sites.
CLOSED P site R248 Extracellular C terminal Other
DHSD1 0.23 0.05 0.03 ND ND
DHSD2 0.15 ND ND ND ND
DHSD3 0.25 ND 0.03 ND ND
DHSD4 0.28 ND ND ND ND
DHSCH1 0.28 ND ND 0.03 0.03
DHSCH2 0.23 0.03 0.08 ND 0.05
DHSCH3 0.13 ND 0.03 ND ND
DHSCH4 ND 0.03 0.05 0.03 0.05
SCH1 0.15 ND 0.03 0.03 0.05
SCH2 0.33 ND ND ND ND
SCH3 0.18 0.03 0.03 ND 0.03
SCH4 0.15 ND 0.03 ND ND
OPENED P site N353 Extracellular C terminal Other
DHSD1 0.05 0.03 0.03 0.03 0.05
DHSD2 0.03 0.05 ND 0.03 ND
DHSD3 0.05 ND 0.03 0.10 0.05
DHSD4 0.08 0.08 0.15 ND 0.20
DHSCH1 0.10 0.03 0.05 0.03 0.10
DHSCH2 0.05 0.13 ND 0.03 0.20
DHSCH3 ND ND ND 0.03 0.05
DHSCH4 0.08 0.08 0.03 ND 0.05
SCH1 0.10 0.05 0.05 ND 0.15
SCH2 0.10 ND ND ND 0.10
SCH3 0.08 0.05 0.05 ND 0.03
SCH4 0.13 0.05 ND ND 0.08
The most preferred binding site of each conformer in bold, “P site” stands for
phosphorylation site. ND, binding to this site was not detected.
hinder the interactions between cytoplasmic domains, and thus,
inhibit the enzyme allosterically. All conformers of all SCH,
DHSCH, and DHSD were able to bind to at least to one
binding pose, but by far the most occupied site was the one
at the interface of N- and P-domains near the phosphorylation
site. It can be occupied by almost all conformers, it is present
in both opened and closed enzyme conformations, and we
experimentally verified binding of all SCH, DHSCH, and DHSD
to the large cytoplasmic segment connecting TM4 and TM5
(C45) using fluorometry.
The C45 constitutes approx. 40% of the enzyme mass and
forms the cytoplasmic domains N and P. It can be overexpressed
without the rest of the enzyme in high quantities in E. coli
(Grycova et al., 2009). So far, all the experiments indicate
that it retains its structure, ability to bind ATP and TNP-ATP
(Kubala et al., 2003a,b, 2004), and dynamic properties (Grycova
et al., 2009; Kubala et al., 2009) as when it is a part of the
entire enzyme. Its solubility greatly facilitates all subsequent
FIGURE 9 | Fluorescence emission spectra of 5 µM SCH (black),
DHSCH (blue) and DHSD (red) in the presence (solid line) or absence
(dotted line) of 5 µM C45. The fluorescence intensity in the spectrum of SCH
in the C45 presence was divided by a factor of 20 to fit the graph.
FIGURE 8 | Zoom on the binding sites of SCH (yellow), DHSCH (cyan) and DHSD (magenta) on cytoplasmic loops in the opened and closed structure.
A, domain is blue; N, domain red; P, domain green.
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experiments and this model system was successfully used for
closer localization of binding sites of numerous other small
molecules on the cytoplasmic part of NKA (Hulicˇiak et al.,
2012; Havlíková et al., 2013). Also in the case of SCH, DHSCH
and DHSD, the spectroscopic experiments unambiguously
confirmed that these molecules interact with C45. Moreover,
in the case of DHSCH and DHSD, we could observe two
peaks in the emission spectra of the protein-bound forms. It
reveals that there are two binding modes of these species to
the C45 and it is in line with predictions from molecular
docking.
In conclusion, flavonolignans are proposed to be a novel class
of NKA inhibitors, and particularly the 2,3-dehydroderivatives
DHSCH and DHSD seem to be very promising agents. The
flavonolignans are distinct from the cardiac glycosides that are
currently used in NKA treatment. Because their binding sites
are different, the mechanism of inhibition is different as well
as the range of active concentrations, one can expect that these
new NKA inhibitors would exhibit also a different biomedical
actions than cardiac glycosides. Currently, the major problem
seems to be the low specificity in interaction with biomolecules,
which is probably partially related to significant number of
stable flavonolignan conformers. Syntheses of more than 100
flavonolignan derivatives have been described (Biedermann
et al., 2014), and further screening could identify a derivative
that would be useful at lower concentrations and with higher
specificity.
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